Ospedale Sacro Cuore Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2008
NCT00626509
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Ospedale Sacro Cuore - Dipartimento di Oncologia Medica | Ospedale Sacro Cuore Don Calabria di Negrar, Oncologia Medica

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Kidney Neoplasms (Phase 2)

Stomach Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 6